{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:45:06Z","timestamp":1784133906332,"version":"3.55.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/md.0000000000003328","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T14:26:47Z","timestamp":1461076007000},"page":"e3328","source":"Crossref","is-referenced-by-count":32,"title":["Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus"],"prefix":"10.1097","volume":"95","author":[{"given":"Ja Yoon","family":"Heo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Up","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Nyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Soo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Hyub","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyon-Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-87-20210226","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.3748\/wjg.v20.i20.6262","article-title":"Management of chronic hepatitis B infection: current treatment guidelines, challenges, and new developments","volume":"20","author":"Tang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R3-87-20210226","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"R4-87-20210226","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/hep.22898","article-title":"The natural history of chronic hepatitis B virus infection","volume":"49","author":"McMahon","year":"2009","journal-title":"Hepatology"},{"key":"R5-87-20210226","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/liv.12395","article-title":"Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?","volume":"34","author":"Calvaruso","year":"2014","journal-title":"Liver Int"},{"key":"R6-87-20210226","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B","volume":"52","author":"Chang","year":"2010","journal-title":"Hepatology"},{"key":"R7-87-20210226","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"R8-87-20210226","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hep.25937","article-title":"Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy","volume":"57","author":"Lai","year":"2013","journal-title":"Hepatology"},{"key":"R9-87-20210226","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/gut.48.2.251","article-title":"Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis","volume":"48","author":"Bolondi","year":"2001","journal-title":"Gut"},{"key":"R10-87-20210226","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"R11-87-20210226","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N Engl J Med"},{"key":"R12-87-20210226","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(09)62195-4","article-title":"Non-invasive assessment of liver fibrosis: are we ready?","volume":"375","author":"Castera","year":"2010","journal-title":"Lancet"},{"key":"R13-87-20210226","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/srep01065","article-title":"A serum \u201csweet-doughnut\u201d protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis","volume":"3","author":"Kuno","year":"2013","journal-title":"Sci Rep"},{"key":"R14-87-20210226","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00535-014-0946-y","article-title":"A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis","volume":"50","author":"Toshima","year":"2015","journal-title":"J Gastroenterol"},{"key":"R15-87-20210226","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.27305","article-title":"Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients","volume":"60","author":"Yamasaki","year":"2014","journal-title":"Hepatology"},{"key":"R16-87-20210226","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00535-014-1007-2","article-title":"Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease","volume":"50","author":"Abe","year":"2015","journal-title":"J Gastroenterol"},{"key":"R17-87-20210226","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ajg.2015.118","article-title":"Serum Wisteria floribunda agglutinin-positive mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis","volume":"110","author":"Umemura","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"R18-87-20210226","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis. An update on terminology and reporting","volume":"19","author":"Batts","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R19-87-20210226","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/prca.201300010","article-title":"Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling","volume":"7","author":"Kuno","year":"2013","journal-title":"Proteomics Clin Appl"},{"key":"R20-87-20210226","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/liv.12628","article-title":"Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment","volume":"35","author":"Kim","year":"2015","journal-title":"Liver Int"},{"key":"R21-87-20210226","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.27735","article-title":"Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis","volume":"61","author":"Kim","year":"2015","journal-title":"Hepatology"},{"key":"R22-87-20210226","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/liv.12678","article-title":"Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B","volume":"35","author":"Park","year":"2015","journal-title":"Liver Int"},{"key":"R23-87-20210226","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1111\/liv.12808","article-title":"Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: a multicentre, retrospective study","volume":"35","author":"Seo","year":"2015","journal-title":"Liver Int"},{"key":"R24-87-20210226","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3350\/kjhep.2009.15.3.391","article-title":"Practice guidelines for management of hepatocellular carcinoma 2009.","volume":"15","year":"2009","journal-title":"Korean J Hepatol"},{"key":"R25-87-20210226","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0168-8278(96)80076-6","article-title":"Elevated serum levels of 90K\/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients","volume":"25","author":"Artini","year":"1996","journal-title":"J Hepatol"},{"key":"R26-87-20210226","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/emboj\/17.6.1606","article-title":"Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin","volume":"17","author":"Sasaki","year":"1998","journal-title":"Embo J"},{"key":"R27-87-20210226","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/j.gastro.2012.06.036","article-title":"Deactivation of hepatic stellate cells during liver fibrosis resolution in mice","volume":"143","author":"Troeger","year":"2012","journal-title":"Gastroenterology"},{"key":"R28-87-20210226","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm1006","article-title":"Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics","volume":"10","author":"Callewaert","year":"2004","journal-title":"Nat Med"},{"key":"R29-87-20210226","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/apt.13431","article-title":"Serum WFA -M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C","volume":"43","author":"Ura","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"R31-87-20210226","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/ajg.2014.157","article-title":"Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy","volume":"109","author":"Lee","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R33-87-20210226","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3748\/wjg.v21.i4.1158","article-title":"Factors associated with significant liver fibrosis assessed using transient elastography in general population","volume":"21","author":"You","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R34-87-20210226","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3350\/cmh.2015.21.1.32","article-title":"The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B","volume":"21","author":"Yo","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"R35-87-20210226","doi-asserted-by":"crossref","first-page":"e35825","DOI":"10.1371\/journal.pone.0035825","article-title":"Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"R36-87-20210226","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0168-8278(02)00413-0","article-title":"A comparison of fibrosis progression in chronic liver diseases","volume":"38","author":"Poynard","year":"2003","journal-title":"J Hepatol"},{"key":"R37-87-20210226","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/hep.1840360707","article-title":"Fibrosis and disease progression in hepatitis C","volume":"36","author":"Marcellin","year":"2002","journal-title":"Hepatology"},{"key":"R38-87-20210226","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","article-title":"Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines","volume":"31","author":"Heathcote","year":"2000","journal-title":"Hepatology"},{"key":"R39-87-20210226","doi-asserted-by":"crossref","first-page":"e0129053","DOI":"10.1371\/journal.pone.0129053","article-title":"Serum Wisteria floribunda agglutinin-positive mac-2 binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis C after sustained virological response","volume":"10","author":"Sasaki","year":"2015","journal-title":"PLoS One"},{"key":"R40-87-20210226","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.1111\/hepr.12466","article-title":"Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients","volume":"45","author":"Tamaki","year":"2015","journal-title":"Hepatol Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T20:20:27Z","timestamp":1748895627000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201604050-00087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":37,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003328","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}